tetano
Editor, Senior Moderator
Afr J Lab Med. 2019 Jul 18;8(1):861. doi: 10.4102/ajlm.v8i1.861. eCollection 2019.
[h=1]Strengthening laboratory capacity for detection of respiratory viral pathogens through the Global Health Security Agenda (GHSA) framework.[/h] Whitaker B[SUP]1[/SUP], Alroy KA[SUP]1[/SUP], Guthrie E[SUP]2[/SUP], Schildecker S[SUP]2[/SUP], Hiers S[SUP]3[/SUP], Woodard J[SUP]3[/SUP], Balajee SA[SUP]1[/SUP].
[h=3]Author information[/h] 1 Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States. 2 Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States. 3 Office of the Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
[h=3]Abstract[/h] [h=4]Background:[/h] Endemic and emerging respiratory viruses are a threat to public health, and a robust public health laboratory system is essential to ensure global health security.
[h=4]Objective:[/h] This program sought to expand molecular laboratory testing capacity to detect a broad range of respiratory pathogens in clinical respiratory specimens collected during disease surveillance and outbreak investigations.
[h=4]Methods:[/h] As a part of the Global Health Security Agenda (GHSA), the United States Centers for Disease Control and Prevention utilised the equipment and training infrastructure already in place at the World Health Organization National Influenza Centers to expand testing capacity for respiratory viruses in laboratories in GHSA partner countries. This was done through the provision of quality assured reagents, including multiplex platforms and technical guidance for laboratory staff, as well as the assessment of laboratory testing accuracy.
[h=4]Conclusion:[/h] Early findings illustrated that GHSA laboratories have been able to expand testing capacity using specimens from routine surveillance, as well as from outbreak situations.
[h=4]KEYWORDS:[/h] global health security; multiplex; polymerase chain reaction.; public health laboratory; respiratory viruses
PMID: 31392168 PMCID: PMC6676779 DOI: 10.4102/ajlm.v8i1.861
[h=1]Strengthening laboratory capacity for detection of respiratory viral pathogens through the Global Health Security Agenda (GHSA) framework.[/h] Whitaker B[SUP]1[/SUP], Alroy KA[SUP]1[/SUP], Guthrie E[SUP]2[/SUP], Schildecker S[SUP]2[/SUP], Hiers S[SUP]3[/SUP], Woodard J[SUP]3[/SUP], Balajee SA[SUP]1[/SUP].
[h=3]Author information[/h] 1 Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States. 2 Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States. 3 Office of the Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
[h=3]Abstract[/h] [h=4]Background:[/h] Endemic and emerging respiratory viruses are a threat to public health, and a robust public health laboratory system is essential to ensure global health security.
[h=4]Objective:[/h] This program sought to expand molecular laboratory testing capacity to detect a broad range of respiratory pathogens in clinical respiratory specimens collected during disease surveillance and outbreak investigations.
[h=4]Methods:[/h] As a part of the Global Health Security Agenda (GHSA), the United States Centers for Disease Control and Prevention utilised the equipment and training infrastructure already in place at the World Health Organization National Influenza Centers to expand testing capacity for respiratory viruses in laboratories in GHSA partner countries. This was done through the provision of quality assured reagents, including multiplex platforms and technical guidance for laboratory staff, as well as the assessment of laboratory testing accuracy.
[h=4]Conclusion:[/h] Early findings illustrated that GHSA laboratories have been able to expand testing capacity using specimens from routine surveillance, as well as from outbreak situations.
[h=4]KEYWORDS:[/h] global health security; multiplex; polymerase chain reaction.; public health laboratory; respiratory viruses
PMID: 31392168 PMCID: PMC6676779 DOI: 10.4102/ajlm.v8i1.861